Cerebral organoids human mini brains in a dish open up new possibilities for dr...
Cerebral organoids human mini brains in a dish open up new possibilities for drug development in neurodegenerative and developmental diseases
Transferring results from animal models to humans is a major bottleneck in pharmaceutical research. This is particularly true for brain disorders, including neurodegenerative and developmental diseases. Both animal models and conv...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MiniBrain
Cerebral Organoids Using stem cell derived 3D cultures to u...
3M€
Cerrado
ProTeAN
Production and Testing of humAn derived Neurons and brain or...
149K€
Cerrado
BRAINtSERS
BRAIN organoids unTanglement with SERS
175K€
Cerrado
COMMER-CELL
Commercialisation of neuronal cell co cultures
100K€
Cerrado
ReprOids
Reprogramming of somatic cells into organOids: patient-centr...
3M€
Cerrado
3D-BrAIn
Revolutionary high-resolution human 3D brain organoid platfo...
2M€
Cerrado
Información proyecto Mini Brains
Duración del proyecto: 18 meses
Fecha Inicio: 2016-12-13
Fecha Fin: 2018-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Transferring results from animal models to humans is a major bottleneck in pharmaceutical research. This is particularly true for brain disorders, including neurodegenerative and developmental diseases. Both animal models and conventional cell culture methods fail to recapitulate the complexity of the human brain and there are fundamental differences in developmental and physiological aspects between humans and the commonly used animal models. The high attrition rate of drugs for brain disorders has led major pharmaceutical companies to severely downsize their respective departments.
To overcome the inherent limitations of current in vitro and in vivo models for brain disorders, we have generated a proprietary human pluripotent stem cell-derived 3D organoid culture system, termed cerebral organoids. These cerebral organoids are ‘mini brains’ that grow in a petri dish , display discrete but interconnected brain regions and recapitulate features of human brain development. ‘Mini Brains’ can be derived from patient-specific stem cells and represent a unique opportunity for creating specific human disease models in a 3D culture.
The aim of the ‘Mini Brain’ project is to investigate the commercial feasibility of cerebral organoids as a new and highly cost-effective tool in the discovery and development of therapies for neurodegenerative and developmental diseases. The use of patient-specific cerebral organoids for drug screening and validation offers an alternative to animal experiments, reducing costs and animal use and improving reliability of results, and has the potential to decrease the cost of drug development, reduce the brain disease burden and increase the rate of approved drugs for brain disorders.